ArticleStandard of Care in HER2-Positive Breast Cancer Unchanged
For most patients with HER2-positive early breast cancer, standard treatment should remain the same, according to new findings. Most women with this type of breast cancer will receive the drug trastuzumab, along with other therapies and surgery.